戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              PEFR gradually returned to pretreatment baseline levels
2                                              PEFR increases over the first 24 h in AHF and could serv
3                                              PEFR, FVC, FEV1, and FEF25-75 all increased with increas
4 ys-off due to asthma [1.203 (1.148; 1.258)], PEFR<80 [0.76 (0.666; 0.854)], non-use of a self-managem
5 2.3+/-0.4 versus 2.1+/-0.4 L, P<0.0005), and PEFR (446+/-55 versus 414+/-56 L. min-1, P<0.005).
6 ceding inspiration when determining FEV1 and PEFR.
7 ependent effects on respiratory symptoms and PEFR in children.
8                              Median baseline PEFR was 225 l/min (interquartile range [IQR]: 160 to 30
9                                  Three daily PEFR measurements (start-of-shift, end-of-shift, and bed
10 urs was associated with a deficit in evening PEFR (-0.5 liters/minute 95% CI -1.4 to 0.4) and increas
11 ity was associated with a deficit in evening PEFR (-0.5 liters/minute, 95% CI -1.2 to 0.2) and increa
12  41 L/min (95% CI: 8 to 74 L/min) in evening PEFR among asthmatic children.
13  time and treatment over 24 h showed greater PEFR improvement after nesiritide compared with placebo
14                                     The 24-h PEFR change related to moderate or marked dyspnea improv
15                                     However, PEFR data were not provided to the pharmacist.
16  6-h postdose average FEV(1) and FVC, and in PEFR, without a significant difference among the differe
17 3 increase in PM10, the estimated decline in PEFR was 13.2 L/min (p = 0.008) for end-of-shift, 9.9 L/
18 steroids group had the greatest declines in %PEFR (1.3%, versus < 0.5% in each of the other three gro
19 ir use; during monthly telephone interviews, PEFR rates were not elicited.
20 low rate (PEFR), and MMEF; and O3 with lower PEFR and MMEF.
21 rial peak expiratory flow rate measurements (PEFR) using a mini-Wright meter.
22 ion was associated with a deficit in morning PEFR (-1.0 liters/minute, 95% confidence interval (CI) -
23 .8, 95% CI 1.0-3.2) and a deficit in morning PEFR (-1.5 liters/minute, 95% CI -2.8 to -0.2).
24  Gly/Gly genotype had an increase in morning PEFR during treatment with regularly scheduled albuterol
25  Arg/Arg genotype had an increase in morning PEFR of 23 L/min (p=0.0162); the change in patients with
26  with the Arg/Arg genotype had lower morning PEFR during treatment with albuterol than during the pla
27 .27), normalized FVC (r = -0.22), normalized PEFR (r = -0.27), low-density lipoprotein (r = 0.24), an
28 d hemoglobin level (r = 0.28) and normalized PEFR (r = -0.23).
29        Hypertension and decreased normalized PEFR are the principal predictors of deep white matter h
30 luded, hypertension and decreased normalized PEFR were predictive of 11.7% of the variance.
31 s of variation for replicate measurements of PEFR, FVC, FEV1, and FEF25-75 were 7.8%, 2.5%, 2.7%, and
32                               Mean values of PEFR, FEV1, and FEF25-75 were 83 +/- 24, 92 +/- 23, and
33 iritide had a greater effect than placebo on PEFR, and this predicted patients with moderate/marked i
34 75) (-8.12%), and peak expiratory flow rate (PEFR) (-4.65%) as compared with children with less than
35 ines in morning % peak expiratory flow rate (PEFR) (1.8% versus 0.3% per 15 ppb ozone, p < 0.05) and
36  0.57) or initial peak expiratory flow rate (PEFR) (51% versus 53% of predicted, p = 0.52).
37 en measured their peak expiratory flow rate (PEFR) every morning and evening, and kept a daily diary
38 addition, morning peak expiratory flow rate (PEFR) improved significantly (mean 9.4%, SEM 3.0%) in th
39  rate (T-PEFR) to peak expiratory flow rate (PEFR) of 10%, 25%, 50%, and 75% (the smaller this ratio
40     We found that peak expiratory flow rate (PEFR) was significantly lower after both a slow inspirat
41           Morning peak expiratory flow rate (PEFR) was the primary outcome variable.
42 hypothesized that peak expiratory flow rate (PEFR) would increase with acute heart failure (AHF) trea
43  lower FVC, FEV1, peak expiratory flow rate (PEFR), and MMEF; and O3 with lower PEFR and MMEF.
44 ate (EEFR) to the peak expiratory flow rate (PEFR; from 10% to 25% to 50% to 75%).
45 pacity [FVC], and peak expiratory flow rate [PEFR]) normalized for subject's height, plasma lipid lev
46                  Peak expiratory flow rates (PEFR) and signs and symptoms were serially monitored.
47 al capacity, and peak expiratory flow rates (PEFR) were also recorded.
48     Microstrain was minimized with an APRV T-PEFR to PEFR ratio of 75% (mean [SEM], 0.05 [0.03]) and
49 H2O (mean [SEM], 0.09 [0.08]), but an APRV T-PEFR to PEFR ratio of 75% also promoted alveolar recruit
50 mproved alveolar recruitment using an APRV T-PEFR to PEFR ratio of 75% may be the mechanism of lung p
51 EP (16-24 cm H2O) and a brief T(low) (APRV T-PEFR to PEFR ratio of 75%) reduced microstrain.
52  termination of peak expiratory flow rate (T-PEFR) to peak expiratory flow rate (PEFR) of 10%, 25%, 5
53 n the usual care group (P =.02) but not than PEFR monitoring controls (P =.28).
54                                          The PEFR monitoring control group (n = 363) received a peak
55 t than the usual care group (P =.03) and the PEFR monitoring group (P =.001) and were more satisfied
56 n, and after three doses of medication their PEFR still did not exceed 40% of the expected value.
57 r PEEP (5-10 cm H2O) and a decreased EEFR to PEFR ratio (</=50%) demonstrated dynamic heterogeneity b
58     Likewise, APRV with an increased EEFR to PEFR ratio (50%-75%) resulted in alveolar occupancy at i
59 4 cm H2O) (P > .01) and an increased EEFR to PEFR ratio (75%) (P > .01).
60 , reducing the time at low pressure (EEFR to PEFR ratio of 75%) in the APRV group provided dynamic ho
61 reas were quantified (using PEEP and EEFR to PEFR ratio) to determine dynamic heterogeneity.
62 ostrain was minimized with an APRV T-PEFR to PEFR ratio of 75% (mean [SEM], 0.05 [0.03]) and PEEP of
63 n [SEM], 0.09 [0.08]), but an APRV T-PEFR to PEFR ratio of 75% also promoted alveolar recruitment com
64 alveolar recruitment using an APRV T-PEFR to PEFR ratio of 75% may be the mechanism of lung protectio
65 4 cm H2O) and a brief T(low) (APRV T-PEFR to PEFR ratio of 75%) reduced microstrain.
66  substudy, 421 patients (37 sites) underwent PEFR testing at baseline, 1, 6, and 24 h after randomiza
67 ; 95% CI: 2.9 to 21.2 L/min) associated with PEFR, but the previous day's ETS exposure was a risk fac
68 2.5 with FEV1 (r = -0.72, p < 0.01), O3 with PEFR (r = -0.75, p < 0.005), and PM2.5 with MMEF (r = -0

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。